Could ETQ's share price be soon to benefit from their developments with the new UVGI Nightingale Mobile Air Filtration Product.

New UVGI air filtration product

In November 2002, the ETQ announced its new Nightingale UVGI air filtration product, to be produced by a new joint-venture company, UVGI Systems Limited, owned 55% by the Group and 45% by Suvair Limited. This rapid response mobile air filtration unit is capable of killing the MRSA super bug and other airborne pathogens.

The UVGI unit has widespread application where there is need to keep
air free of dangerous live bacteria, viruses, and fungal spores, including
hospitals, schools, cruise liners, aircraft, food processing, and military
applications.

The UVGI unit uses a high intensity Ultra Violet Germicidal Irradiation ('UVGI')
filter, which has been designed to control harmful and dangerous airborne
pathogens, such as Anthrax, Tuberculosis, and Staphylococcus aureus, the
causative agent in MRSA. The filtration system is combined with use of high
intensity Ultra Violet light, which inactivates micro organisms by disrupting
their DNA structure.

Tests of a prototype at the Defence Science Technology Laboratory ('Dstl') at
Porton Down, the centre for excellence for the Ministry of Defence, showed that
the UVGI unit captured and/or destroyed more than 99.9% of Bacillus subtilis
spores, a simulant for Anthrax bacteria.

Since November, second generation units have been developed, which will go on
applications testing at an NHS Trust Hospital in December 2003, following
building completion of its new haematology unit. It is also anticipated the
UVGI unit will shortly go on laboratory testing in the United States with
contractors nominated by the Department of Homeland Security.

Concern seems to be hotting up on the T.V. news that the MRSA super bug is still killing and disabling people visiting or as patients in NH Trust hospitals. It would be surprising if NH Trust hospital do not notice and Buy this product before they get to many expensive law suits for compensation claims.

Definitely a stock that could soon be heading north. Worth buying in but DYOR

L.

RELATED NEWS LINKS

Sky News Sun 28th Sept 03 - NEW ANTIBIOTICS WARNING
BBC World News Thurs 4th December 03 - Hospital infections: Case studies
BBC World News Fri 5th Dec 03 - 'Superbug' crackdown is launched
BBC World News Monday 22nd Dec 03 - Superbugs lurk in intensive care
Sky News Sun 14th Dec 03 - SUPERBUG CARRIED BY PETS
BBC World News Thurs 26th Feb 04 - Superbug deaths increase 15-fold
BBC World News Mon 22nd March 04 - MRSA superbug hits more children
BBC World News Fri 2nd April 04 - Superbug outbreak in cardiac ward
BBC World News Thurs 8th April 04 - NHS faces superbug legal claims
BBC World News Sun 6th June 04 - Government 'complacent' over MRSA
BBC World News Fri 18th June 04 - Superbug deaths 'set to double'
BBC World News Thurs 1st July 04 - Holland's tough line combats MRSA
BBC World News Thurs 1st July 04 - Overcrowded hospitals breed MRSA
ITV.com Fri 9th July 04 - Mother's MRSA nightmare
ITV.com Fri 9th July 04 - 'MRSA superbug has done this to me'
ITV.com Fri 9th July 04 - Precautions you can take against MRSA
Sky News Sun 11th July 04 - WAR DECLARED ON MRSA
BBC UK News Mon 12th July 04 - Drive to fight hospital superbugs

Have any of you guys checked out the UVGI site recently...some interesting facts on infection control.

Yes saw the new products the other day.

Yes BMW I have seen it.

It is very positive & should help them with their share issue BUT wait until the shares have dropped & maybe look next year especially with a 23% spread.

See below.

-------------------------------------------

apple - 27 Apr'04 - 09:31 - 66 of 82


As I said before UVGI air filtration is a small part of their business & the portable unit is not cheap enough & full scale building aircon version not on the horizon.

One to avoid!

Massive share dilution.

Move to AIM so that ISA holders are FORCED to SELL.

Bad track record.

Take another look this time next year.

AIM - Tax advantage

Bad track record ?

Dilution - Maybe there is a reason !

Bid rumour in the papers today.

Hi Happy1

Thanks for the update which paper is it in?

EVO intiate coverage with a BUY recommendation

http://www.evbgresearch.com/docview.asp?document=3339

UK smallcap opening - Energy Technique up on product sale in US
AFX


LONDON (AFX) - Energy Technique was a prime mover after news that the company has sold its first Nightingale air filtration system -- developed to kill the MRSA hospital superbug, TB, and other dangerous germs -- into the US healthcare system.

The first unit will be sold to the Northwest Hospital Center in Randallstown, Maryland, the company said.

Nightingale uses ultraviolet radiation combined with air flow systems to attack the DNA of killer germs such as the MRSA hospital superbug, anthrax and TB.

Energy shares were 1.50 firmer at 5.50 pence by 8.33 am.


Surely this now leads to sustainable growth in the longer term as the title of this thread suggested almost one year ago!

Suprising that it coincides with the MRSA news. Expect a positive update from the Basingstoke trials soon !

Yoyo

Look at the chart, there have been sudden spikes like this before.

It will fall back again & the downward trend will continue.

The Nightingale is too expensive, see my previous posts starting at post 21 & especially post 38.

Click on the All messages button & read this thread.

I know that Happy1 will disagree because he bought in much higher & wants it to recover.

I think Happy1 is wrong about this one but he was right about Superscape so he is probably much happier about that.

apple you were saying it is only for rent not for sale. You are a bloody deramper by the looks of things. You would have told people not to buy at 4p and then denied them of a 43% rise in their money !!

Issued by First City Financial Ltd

PRESS RELEASE

First sale of Nightingale bug killer into US health system NHS targetted
July 7, 2004: Energy Technique plc has sold its Nightingale air filtration system - developed to kill the MRSA hospital superbug, TB, and other dangerous germs - into the US healthcare system.

The breakthrough sale comes as Energy Technique continues discussions to use
Nightingale within the National Health Service.

The first unit sold in the US will be used by the Northwest Hospital Center in
Randallstown, Maryland. Other sales to US hospitals are expected to follow through Energy Techniques partnership with the US manufacturer, NQ Environmental.

Energy Technique Managing Director Leigh Stimpson said: Following the careful
development and pre-marketing work we have put into Nightingale, this landmark
early sale is great news for Energy Technique.

We are confident it will strengthen our case for this product to be used within the NHS, where its powerful infection control capabilities could have enormous impact.

Energy Technique is currently discussing numerous prospects with several NHS
trusts following successful trials of Nightingale at the Health Protection Agency laboratories at Porton Down. Two units are currently undergoing clinical trials with the Basingstoke NHS Trust in Hampshire.

Nightingale uses ultraviolet radiation combined with sophisticated air flow systems to attack the DNA of killer germs such as the MRSA hospital superbug, anthrax and TB.

First announced at the end of 2002 following prototype testing, the system has
subsequently undergone further development ahead of extensive commercial
marketing.

For further information contact:
Leigh Stimpson, Managing Director, Energy Technique plc: 07919 214 882
07879 845 288
Allan Piper, First City Financial Public Relations: 020 7436 7486
07736 064 982
www.energytechniqueplc.com Ticker symbol: ETQ

Apple I hear what you are saying, but the previous spikes are to be somewhat expected when a stock has been purely speculative. The product is now in the market place as fact and is no longer fiction. To get a new product into the high street shops is not easy, ask James Dyson. ETQ have jumped THE major hurdle and have an exciting future.

no UP 68.7%

That is more than just a spike, it's a VERY NICE SPIKE!


Last year, I phoned the company & Joe Tufo said the Lease is 2000/Year

PLUS

4000/Year Maintainence

Has this changed?

I suggest that you phone the company & ask especially before diving in after a 68.7% rise!

Head office
Tel: +44 (0) 208 783 0033
Fax: +44 (0) 208 941 7780
Basingstoke office
Tel: +44 (0) 1256 814162
Fax: +44 (0) 1256 817815

Joe Tufo
Direct: +44 (0) 1256 383438
Tel: +44 (0) 1256 817815
Mobile: +44 (0) 7050 276 720
Fax: +44 (0) 1256 358561
Email: joe@uvgi.co.uk

I think that if you are in then it is time to get out!

Good luck!

apple read the RNS - Here I will help you

S O L D

SOLD/BOUGHT/CUSTOMER HAS PAID MONEY

Kapiche ?

Regardless of your old bit of news your stuburness has made yourself lose an awaful amount of potential money !

Happy1

Don't start personal attacks just be happy that you can get some of your money back.

I guess from your posts since January that you need more than 10p to get all your money back.

Good luck!

Yep, I missed a nice big spike but we can all say that with hindsight.
A hindsight of a temporary speculative spike.

It has already fallen back & I will be very surprised if it gets to 10p within a year.

Be happy with your recent gains on SPS, you picked a very good one there!

Not personal just annoyed with your ramblings. No I am sitting on free shares having sold out at 15p keeping the profit in stock ;-)

Hold on wave 2

Wednesday July 7, 04:31 PM

Related Quotes
Energy Technique PLC
ETQ.L
6.25
+2.25

More on Yahoo! Finance
The Latest Share Tips
Breaking Financial News
Mortgage Advice
Insurance Quotes

Energy Technique makes strong gains on upbeat product news
Energy Technique (LSE: ETQ.L - news) shares were up by 56.3 per cent at 6.3p in late trade in London on Wednesday after it announced the sale of its first Nightingale air filtration system - designed to kill the hospital superbug MRSA, TB and other dangerous germs - to the US healthcare system.

The company said the sale strengthened its case for the product to be used in the NHS.

Click here for more from FT.com

London & Boston has a is a big share holder in Energy Techniquesee see details below. Have a look at L&B web site it seems to be moving in the right direction at last.

Energy Technique Plc


In accordance with the Companys enhancement policy, London & Boston organised a consortium (including Harrell, the Chairman of Rotch, a company connected with the family of Geoffrey Dart and London & Boston) to invest 1.1m for 50.2% of Energy Technique, which has a full listing on the London Stock Exchange. The investment was completed on 15 June 2001. At that time London & Boston invested 230,354 in cash and 182,000 by the issue to Energy Technique of 1,820,000 Existing Ordinary Shares of 2p each in London & Boston at 10p each in exchange for the issue to London & Boston of ordinary shares in Energy Technique representing approximately 18.81% of Energy Techniques share capital plus options over a further 4% of this company exercisable within 5 years. Geoffrey Dart resigned as chairman of the company and Graham Mackenzie was appointed. Stephen Komly remains the senior non-executive director.

First established in 1879, Energy Technique specialises in the design, manufacture and distribution of high quality air conditioning and heating products. With an impressive customer list, including the Houses of Parliament, Nat West, HSBC and Barclays Banks, Marks & Spencer, Land Securities and Hilton hotels, The Savoy and Claridges hotels. The company has developed a high tech, energy saving, air conditioning system called the Ambassador System for commercial and hotel use. The consortium has brought and will continue to bring new introductions and business opportunities to expand Energy Techniques core Diffusion business.

The company has caused considerable excitement due to its innovative development of a system which removes all known airborne pathogens. The Company won the Fastest Moving Share Award for 2002 rising to 30p per share at one point from the 3p at which London & Boston arranged the re-financing of the company in June 2001

Well a retractment was expected.

Now time to add further.

TODAYS FINANCIAL TIMES mentions ENERGY TECHNIQUE as one of the SHINERS of last week stating that with the USA deal the UK deals with the NHS should follow due to this breakthrough! Give this a few more months and this should be at a reasonable level. The pattern so far has been like TADPOLE and YOOMEDIA a doubling of shareprice with a slight dip back and then onwards with more deals no doubt. We should see 20p within months I reckon -good luck all that are in!!